Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil

The dissolution profile for solid pharmaceutical forms containing chloramphenicol 250 mg available in Brazil was determined using a method from the American Pharmacopoeia (United States Pharmacopoeia, 2004) and then compared. Two different methods of dissolution profile comparison were used: ANOVA,...

Full description

Bibliographic Details
Main Authors: Humberto Gomes Ferraz, Leticia Norma Carpentieri, Sayuri Pereira Watanabe
Format: Article
Language:English
Published: Instituto de Tecnologia do Paraná (Tecpar) 2007-01-01
Series:Brazilian Archives of Biology and Technology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132007000100007
id doaj-df1479ba07d74b5ea47e00d67f7b77cc
record_format Article
spelling doaj-df1479ba07d74b5ea47e00d67f7b77cc2020-11-25T00:10:57ZengInstituto de Tecnologia do Paraná (Tecpar)Brazilian Archives of Biology and Technology1516-89131678-43242007-01-01501576510.1590/S1516-89132007000100007Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in BrazilHumberto Gomes FerrazLeticia Norma CarpentieriSayuri Pereira WatanabeThe dissolution profile for solid pharmaceutical forms containing chloramphenicol 250 mg available in Brazil was determined using a method from the American Pharmacopoeia (United States Pharmacopoeia, 2004) and then compared. Two different methods of dissolution profile comparison were used: ANOVA, and an independent model. Differences between the formulations were reflected in the dissolution profiles. The presence of metastable polymorphs or amorphous forms of chloramphenicol palmitate might be responsible for variations in the concentration of the drug observed within formulations.<br>O perfil de dissolução de formas farmacêuticas sólidas contendo palmitato de cloranfenicol 250 mg disponíveis no Brasil foi determinada pelo método da Farmacopéia Americana (United States Pharmacopeia, 2004) e comparado. Duas categorias de métodos para comparação dos perfis de dissolução foram utilizadas: ANOVA e modelo independente. Diferenças entre as formulações foram refletidas nos perfis de dissolução. A presença de polimorfos metaestáveis ou formas amorfas de palmitato de cloranfenicol pode ser responsável pelas variações na concentração do fármaco observada nas formulações.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132007000100007ChloramphenicolDissolutionPolymorphism
collection DOAJ
language English
format Article
sources DOAJ
author Humberto Gomes Ferraz
Leticia Norma Carpentieri
Sayuri Pereira Watanabe
spellingShingle Humberto Gomes Ferraz
Leticia Norma Carpentieri
Sayuri Pereira Watanabe
Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
Brazilian Archives of Biology and Technology
Chloramphenicol
Dissolution
Polymorphism
author_facet Humberto Gomes Ferraz
Leticia Norma Carpentieri
Sayuri Pereira Watanabe
author_sort Humberto Gomes Ferraz
title Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
title_short Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
title_full Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
title_fullStr Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
title_full_unstemmed Dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in Brazil
title_sort dissolution profile evaluation of solid pharmaceutical forms containing chloramphenicol marketed in brazil
publisher Instituto de Tecnologia do Paraná (Tecpar)
series Brazilian Archives of Biology and Technology
issn 1516-8913
1678-4324
publishDate 2007-01-01
description The dissolution profile for solid pharmaceutical forms containing chloramphenicol 250 mg available in Brazil was determined using a method from the American Pharmacopoeia (United States Pharmacopoeia, 2004) and then compared. Two different methods of dissolution profile comparison were used: ANOVA, and an independent model. Differences between the formulations were reflected in the dissolution profiles. The presence of metastable polymorphs or amorphous forms of chloramphenicol palmitate might be responsible for variations in the concentration of the drug observed within formulations.<br>O perfil de dissolução de formas farmacêuticas sólidas contendo palmitato de cloranfenicol 250 mg disponíveis no Brasil foi determinada pelo método da Farmacopéia Americana (United States Pharmacopeia, 2004) e comparado. Duas categorias de métodos para comparação dos perfis de dissolução foram utilizadas: ANOVA e modelo independente. Diferenças entre as formulações foram refletidas nos perfis de dissolução. A presença de polimorfos metaestáveis ou formas amorfas de palmitato de cloranfenicol pode ser responsável pelas variações na concentração do fármaco observada nas formulações.
topic Chloramphenicol
Dissolution
Polymorphism
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132007000100007
work_keys_str_mv AT humbertogomesferraz dissolutionprofileevaluationofsolidpharmaceuticalformscontainingchloramphenicolmarketedinbrazil
AT leticianormacarpentieri dissolutionprofileevaluationofsolidpharmaceuticalformscontainingchloramphenicolmarketedinbrazil
AT sayuripereirawatanabe dissolutionprofileevaluationofsolidpharmaceuticalformscontainingchloramphenicolmarketedinbrazil
_version_ 1725406085711396864